Cell-Based Potassium Ion Channel Screening Using the FluxOR™ Assay

被引:50
作者
Beacham, Daniel W. [1 ]
Blackmer, Trillium [1 ]
O'Grady, Michael [1 ]
Hanson, George T. [1 ]
机构
[1] Life Technol Corp, Invitrogen Mol Probes, Cellular Syst Div, Eugene, OR 97402 USA
关键词
FluxOR (TM); potassium ion channel; high-throughput screening; flux; BacMam; POTENT; EPILEPSY; MUTATION; KCNQ2; SELECTIVITY; ANTAGONIST; INHIBITOR; RECEPTORS;
D O I
10.1177/1087057109359807
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
FluxOR (TM) technology is a cell-based assay used for high-throughput screening measurements of potassium channel activity. Using thallium influx as a surrogate indicator of potassium ion channel activity, the FluxOR (TM) Potassium Ion Channel Assay is based on the activation of a novel fluorescent dye. This indicator reports channel activity with a large fluorogenic response and is proportional to the number of open potassium channels on the cell, making it extremely useful for studying K+ channel targets. In contrast to BTC-AM ester, FluxOR (TM) dye is roughly 10-fold more thallium sensitive, requiring much lower thallium for a larger signal window. This also means that the assay is carried out in a physiological, normal-chloride saline. In this article, the authors describe how they used BacMam gene delivery to express Kv7.2 and 7.3 (KCNQ), Kir2.1, or Kv11.1 (hERG) potassium ion channels in U2-OS cells. Using these cells, they ran the FluxOR (TM) assay to identify and characterize channel-specific inhibitory compounds discovered within the library (Tocriscreen (TM) Mini 1200 and Sigma Sodium/Potassium Modulators Ligand set). The FluxOR (TM) assay was able to identify several known specific inhibitors of Kv7.2/7.3 or hERG, highlighting its potential to identify novel and more efficacious small-molecule modulators. (Journal of Biomolecular Screening 2010:441-446)
引用
收藏
页码:441 / 446
页数:6
相关论文
共 19 条
[1]   WORTMANNIN IS A POTENT PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR - THE ROLE OF PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE IN NEUTROPHIL RESPONSES [J].
ARCARO, A ;
WYMANN, MP .
BIOCHEMICAL JOURNAL, 1993, 296 :297-301
[2]   HALOPERIDOL DECANOATE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PSYCHOSIS [J].
BERESFORD, R ;
WARD, A .
DRUGS, 1987, 33 (01) :31-49
[3]   A potassium channel mutation in neonatal human epilepsy [J].
Biervert, C ;
Schroeder, BC ;
Kubisch, C ;
Berkovic, SF ;
Propping, P ;
Jentsch, TJ ;
Steinlein, OK .
SCIENCE, 1998, 279 (5349) :403-406
[4]   GBR-12783, A POTENT AND SELECTIVE INHIBITOR OF DOPAMINE UPTAKE - BIOCHEMICAL-STUDIES INVIVO AND EXVIVO [J].
BONNET, JJ ;
COSTENTIN, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 121 (02) :199-209
[5]  
Cavero Icilio, 2005, Expert Opin Drug Saf, V4, P509, DOI 10.1517/14740338.4.3.509
[6]   POTENT SELECTIVE INHIBITORS OF PROTEIN KINASE-C [J].
DAVIS, PD ;
HILL, CH ;
KEECH, E ;
LAWTON, G ;
NIXON, JS ;
SEDGWICK, AD ;
WADSWORTH, J ;
WESTMACOTT, D ;
WILKINSON, SE .
FEBS LETTERS, 1989, 259 (01) :61-63
[7]   Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel [J].
Dedek, K ;
Kunath, B ;
Kananura, C ;
Reuner, U ;
Jentsch, TJ ;
Steinlein, OK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :12272-12277
[8]   IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels [J].
Harmar, Anthony J. ;
Hills, Rebecca A. ;
Rosser, Edward M. ;
Jones, Martin ;
Buneman, O. Peter ;
Dunbar, Donald R. ;
Greenhill, Stuart D. ;
Hale, Valerie A. ;
Sharman, Joanna L. ;
Bonner, Tom I. ;
Catterall, William A. ;
Davenport, Anthony P. ;
Delagrange, Philippe ;
Dollery, Colin T. ;
Foord, Steven M. ;
Gutman, George A. ;
Laudet, Vincent ;
Neubig, Richard R. ;
Ohlstein, Eliot H. ;
Olsen, Richard W. ;
Peters, John ;
Pin, Jean-Philippe ;
Ruffolo, Robert R. ;
Searls, David B. ;
Wright, Mathew W. ;
Spedding, Michael .
NUCLEIC ACIDS RESEARCH, 2009, 37 :D680-D685
[9]   Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels [J].
Hougaard, C. ;
Eriksen, B. L. ;
Jorgensen, S. ;
Johansen, T. H. ;
Dyhring, T. ;
Madsen, L. S. ;
Strobaek, D. ;
Christophersen, P. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (05) :655-665
[10]   Ion channels as drug targets: The next GPCRs [J].
Kaczorowski, Gregory J. ;
McManus, Owen B. ;
Priest, Birgit T. ;
Garcia, Maria L. .
JOURNAL OF GENERAL PHYSIOLOGY, 2008, 131 (05) :399-405